{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:38:14Z","timestamp":1790127494761,"version":"4.0.1"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,7]],"date-time":"2027-05-07T00:00:00Z","timestamp":1809648000000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL17480"],"award-info":[{"award-number":["R01HL17480"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.atherosclerosis.2026.120774","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:01:01Z","timestamp":1777590061000},"page":"120774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Emerging role of ceramides and other sphingolipids in atherosclerosis"],"prefix":"10.1016","volume":"417","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5992-5433","authenticated-orcid":false,"given":"Hanming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianna","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajaira","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-1924","authenticated-orcid":false,"given":"Carlos","family":"Fern\u00e1ndez-Hernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.120774_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: recent developments","volume":"185","author":"Bj\u00f6rkegren","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2018.00130","article-title":"Endothelial transcytosis of lipoproteins in atherosclerosis","volume":"5","author":"Zhang","year":"2018","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOL.0000000000000701","article-title":"Transport of LDLs into the arterial wall: impact in atherosclerosis","volume":"31","author":"Zhang","year":"2020","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cmet.2009.06.003","article-title":"Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis","volume":"10","author":"Fern\u00e1ndez-Hernando","year":"2009","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120774_bib6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0022-2275(20)31964-7","article-title":"Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions","volume":"41","author":"O\u00f6rni","year":"2000","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.201412052","article-title":"Recent insights into the cellular biology of atherosclerosis","volume":"209","author":"Tabas","year":"2015","journal-title":"J Cell Biol"},{"issue":"9753","key":"10.1016\/j.atherosclerosis.2026.120774_bib8","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"10059","key":"10.1016\/j.atherosclerosis.2026.120774_bib9","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","article-title":"Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges","volume":"14","author":"Sampson","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib11","article-title":"Non-traditional lipid biomarkers in atherosclerotic cardiovascular disease: pathophysiological mechanisms and strategies to address residual risk","volume":"16","author":"Wang","year":"2025","journal-title":"Front Endocrinol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides \u2013 lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120774_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1152\/physrev.00008.2023","article-title":"Ceramides are fuel gauges on the drive to cardiometabolic disease","volume":"104","author":"Wilkerson","year":"2024","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120774_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5102","key":"10.1016\/j.atherosclerosis.2026.120774_bib15","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.8456305","article-title":"Programmed cell death induced by ceramide","volume":"259","author":"Obeid","year":"1993","journal-title":"Science"},{"issue":"6451","key":"10.1016\/j.atherosclerosis.2026.120774_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.aav3722","article-title":"Targeting a ceramide double bond improves insulin resistance and hepatic steatosis","volume":"365","author":"Chaurasia","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fendo.2019.00665","article-title":"Inhibiting ceramide synthesis attenuates hepatic steatosis and fibrosis in rats with non-alcoholic fatty liver disease","volume":"10","author":"Jiang","year":"2019","journal-title":"Front Endocrinol"},{"issue":"557","key":"10.1016\/j.atherosclerosis.2026.120774_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8798","article-title":"Targeting acid ceramidase inhibits YAP\/TAZ signaling to reduce fibrosis in mice","volume":"12","author":"Alsamman","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plipres.2015.09.002","article-title":"Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate","volume":"61","author":"Gomez-Mu\u00f1oz","year":"2016","journal-title":"Prog Lipid Res"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120774_bib20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 haploinsufficiency inhibits \u03b2-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib21","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.cell.2019.05.008","article-title":"CerS6-Derived sphingolipids interact with mff and promote mitochondrial fragmentation in obesity","volume":"177","author":"Hammerschmidt","year":"2019","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jbior.2016.10.002","article-title":"Ceramidases, roles in sphingolipid metabolism and in health and disease","volume":"63","author":"Coant","year":"2017","journal-title":"Adv Bio Regul"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120774_bib25","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.tips.2021.10.001","article-title":"Cholesterol - the devil you know; ceramide - the devil you don't","volume":"42","author":"Tippetts","year":"2021","journal-title":"Trends Pharmacol Sci"},{"issue":"29","key":"10.1016\/j.atherosclerosis.2026.120774_bib26","doi-asserted-by":"crossref","first-page":"25847","DOI":"10.1074\/jbc.R200008200","article-title":"The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind","volume":"277","author":"Hannun","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/978-1-4419-6741-1_6","article-title":"Ceramide in stress response","volume":"688","author":"Nikolova-Karakashian","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"39","key":"10.1016\/j.atherosclerosis.2026.120774_bib28","doi-asserted-by":"crossref","first-page":"Pe27","DOI":"10.1126\/sageke.2003.39.pe27","article-title":"Ceramide, stress, and a \"LAG\" in aging","volume":"2003","author":"Obeid","year":"2003","journal-title":"Sci Aging Knowl Environ"},{"issue":"29","key":"10.1016\/j.atherosclerosis.2026.120774_bib29","doi-asserted-by":"crossref","first-page":"25843","DOI":"10.1074\/jbc.R200009200","article-title":"De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway","volume":"277","author":"Merrill","year":"2002","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.120774_bib30","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1073\/pnas.0811269106","article-title":"Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities","volume":"106","author":"Han","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"39","key":"10.1016\/j.atherosclerosis.2026.120774_bib31","doi-asserted-by":"crossref","first-page":"26322","DOI":"10.1074\/jbc.M109.023192","article-title":"The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases","volume":"284","author":"Hornemann","year":"2009","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.120774_bib32","doi-asserted-by":"crossref","first-page":"14595","DOI":"10.1074\/jbc.M114.603860","article-title":"L-Serine deficiency elicits intracellular accumulation of cytotoxic deoxysphingolipids and lipid body Formation","volume":"290","author":"Esaki","year":"2015","journal-title":"J Biol Chem"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.120774_bib33","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1815111","article-title":"Serine and lipid metabolism in macular disease and peripheral neuropathy","volume":"381","author":"Gantner","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.120774_bib34","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1074\/jbc.M109.092973","article-title":"Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids","volume":"285","author":"Penno","year":"2010","journal-title":"J Biol Chem"},{"issue":"46","key":"10.1016\/j.atherosclerosis.2026.120774_bib35","doi-asserted-by":"crossref","first-page":"14646","DOI":"10.1523\/JNEUROSCI.2536-09.2009","article-title":"Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1","volume":"29","author":"Eichler","year":"2009","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120774_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbalip.2018.12.013","article-title":"1-Deoxysphingolipids","volume":"1864","author":"Lone","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.120774_bib37","doi-asserted-by":"crossref","first-page":"15380","DOI":"10.1074\/jbc.R115.658823","article-title":"1-Deoxysphingolipids Encountered Exogenously and Made de Novo: dangerous Mysteries inside an Enigma","volume":"290","author":"Duan","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-3-030-21162-2_4","article-title":"A stroll Down the CerS Lane","volume":"1159","author":"Zelnik","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120774_bib39","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1074\/jbc.M707386200","article-title":"Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate","volume":"283","author":"Laviad","year":"2008","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.319","article-title":"Mammalian ceramide synthases","volume":"62","author":"Levy","year":"2010","journal-title":"IUBMB Life"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120774_bib41","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1172\/JCI63888","article-title":"Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes","volume":"122","author":"Russo","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molmet.2018.12.008","article-title":"The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach","volume":"21","author":"Raichur","year":"2019","journal-title":"Mol Metabol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120774_bib43","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120774_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-5793(97)01187-3","article-title":"Conversion of dihydroceramide to ceramide occurs at the cytosolic face of the endoplasmic reticulum","volume":"416","author":"Michel","year":"1997","journal-title":"FEBS Lett"},{"issue":"36","key":"10.1016\/j.atherosclerosis.2026.120774_bib45","doi-asserted-by":"crossref","first-page":"22432","DOI":"10.1074\/jbc.272.36.22432","article-title":"Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide","volume":"272","author":"Michel","year":"1997","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"10.1016\/j.atherosclerosis.2026.120774_bib46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/bj20031425","article-title":"DES2 protein is responsible for phytoceramide biosynthesis in the mouse small intestine","volume":"379","author":"Omae","year":"2004","journal-title":"Biochem J"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib47","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/cr2002917","article-title":"Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics","volume":"111","author":"Merrill","year":"2011","journal-title":"Chem Rev"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.120774_bib48","doi-asserted-by":"crossref","first-page":"8650","DOI":"10.1016\/S0021-9258(19)38937-9","article-title":"Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus","volume":"265","author":"Futerman","year":"1990","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib49","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41580-024-00742-y","article-title":"Regulation of cellular and systemic sphingolipid homeostasis","volume":"25","author":"Kuo","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2026.120774_bib50","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1021\/bi002836k","article-title":"Enzymes of sphingolipid metabolism: from modular to integrative signaling","volume":"40","author":"Hannun","year":"2001","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120774_bib51","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pharep.2015.12.008","article-title":"Regulation of sphingomyelin metabolism","volume":"68","author":"Bienias","year":"2016","journal-title":"Pharmacol Rep"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.120774_bib52","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1016\/S0021-9258(18)93007-3","article-title":"Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs","volume":"266","author":"Schuchman","year":"1991","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120774_bib53","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1074\/jbc.273.7.4081","article-title":"Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling","volume":"273","author":"Marathe","year":"1998","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib54","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1074\/jbc.273.5.2738","article-title":"Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development","volume":"273","author":"Schissel","year":"1998","journal-title":"J Biol Chem"},{"issue":"31","key":"10.1016\/j.atherosclerosis.2026.120774_bib55","doi-asserted-by":"crossref","first-page":"18431","DOI":"10.1074\/jbc.271.31.18431","article-title":"Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene","volume":"271","author":"Schissel","year":"1996","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2026.120774_bib56","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1432-1033.1997.511_1a.x","article-title":"Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis","volume":"243","author":"Ferlinz","year":"1997","journal-title":"Eur J Biochem"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120774_bib57","first-page":"205","article-title":"Sphingomyelinases and Niemann-Pick disease","volume":"24","author":"Levade","year":"1986","journal-title":"J Clin Chem Clin Biochem"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120774_bib58","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2337\/db10-0550","article-title":"The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models","volume":"60","author":"Opreanu","year":"2011","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib59","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1016\/S0021-9258(18)83553-0","article-title":"A new Zn2+-stimulated sphingomyelinase in fetal bovine serum","volume":"264","author":"Spence","year":"1989","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120774_bib60","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1073\/pnas.97.11.5895","article-title":"Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase","volume":"97","author":"Hofmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.120774_bib61","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1074\/jbc.M611249200","article-title":"Neutral sphingomyelinase 2 is palmitoylated on multiple cysteine residues. Role of palmitoylation in subcellular localization","volume":"282","author":"Tani","year":"2007","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120774_bib62","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1073\/pnas.95.7.3638","article-title":"Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?","volume":"95","author":"Tomiuk","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2026.120774_bib63","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1074\/jbc.M511306200","article-title":"Novel tumor necrosis factor-responsive Mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein","volume":"281","author":"Krut","year":"2006","journal-title":"J Biol Chem"},{"issue":"Pt 20","key":"10.1016\/j.atherosclerosis.2026.120774_bib64","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1242\/jcs.114.20.3727","article-title":"Nuclear localization of neutral sphingomyelinase 1: biochemical and immunocytochemical analyses","volume":"114","author":"Mizutani","year":"2001","journal-title":"J Cell Sci"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120774_bib65","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbagen.2014.11.019","article-title":"Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization","volume":"1850","author":"Rajagopalan","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.120774_bib66","doi-asserted-by":"crossref","first-page":"17993","DOI":"10.1074\/jbc.M110.102988","article-title":"Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the Mammalian sphingomyelin phosphodiesterase 5","volume":"285","author":"Wu","year":"2010","journal-title":"J Biol Chem"},{"issue":"40","key":"10.1016\/j.atherosclerosis.2026.120774_bib67","doi-asserted-by":"crossref","first-page":"38528","DOI":"10.1074\/jbc.M305437200","article-title":"Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family","volume":"278","author":"Duan","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib68","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1194\/jlr.M300037-JLR200","article-title":"Purification, localization, and expression of human intestinal alkaline sphingomyelinase","volume":"44","author":"Duan","year":"2003","journal-title":"J Lipid Res"},{"issue":"47","key":"10.1016\/j.atherosclerosis.2026.120774_bib69","doi-asserted-by":"crossref","first-page":"34372","DOI":"10.1074\/jbc.M703329200","article-title":"Recycling of sphingosine is regulated by the concerted actions of sphingosine-1-phosphate phosphohydrolase 1 and sphingosine kinase 2","volume":"282","author":"Le Stunff","year":"2007","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120774_bib70","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1074\/jbc.M209514200","article-title":"Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2","volume":"278","author":"Ogawa","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120774_bib71","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molcel.2012.04.033","article-title":"The Sj\u00f6gren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway","volume":"46","author":"Nakahara","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-511X-9-15","article-title":"Ceramide and ceramide 1-phosphate in health and disease","volume":"9","author":"Arana","year":"2010","journal-title":"Lipids Health Dis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib73","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cellsig.2010.11.012","article-title":"Ceramide kinase: the first decade","volume":"23","author":"Bornancin","year":"2011","journal-title":"Cell Signal"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120774_bib74","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1194\/jlr.M500313-JLR200","article-title":"Substrate specificity of human ceramide kinase","volume":"46","author":"Wijesinghe","year":"2005","journal-title":"J Lipid Res"},{"issue":"7463","key":"10.1016\/j.atherosclerosis.2026.120774_bib75","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature12332","article-title":"Non-vesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoids","volume":"500","author":"Simanshu","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib76","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3945\/an.113.004333","article-title":"Lipidomics technologies at the end of the first decade and the beginning of the next","volume":"4","author":"Merrill","year":"2013","journal-title":"Adv Nutr"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4419-6741-1_10","article-title":"Extracellular and intracellular actions of sphingosine-1-phosphate","volume":"688","author":"Strub","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12010143","article-title":"Sphingolipids and atherosclerosis: the dual role of ceramide and Sphingosine-1-Phosphate","volume":"12","author":"Piccoli","year":"2023","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1083\/jcb.114.1.155","article-title":"Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation","volume":"114","author":"Zhang","year":"1991","journal-title":"J Cell Biol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120774_bib80","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/ATVBAHA.124.321158","article-title":"Ying and Yang of ceramide in the vascular endothelium","volume":"44","author":"SenthilKumar","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120774_bib81","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1074\/jbc.M210375200","article-title":"Transient mechanoactivation of neutral sphingomyelinase in caveolae to generate ceramide","volume":"278","author":"Czarny","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108225","article-title":"Sphingomyelinase disables inactivation in endogenous PIEZO1 channels","volume":"33","author":"Shi","year":"2020","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/CIRCRESAHA.123.323445","article-title":"Necessary role of ceramides in the human microvascular endothelium during health and disease","volume":"134","author":"SenthilKumar","year":"2024","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib84","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/HYPERTENSIONAHA.119.14507","article-title":"Endothelial Sphingolipid De Novo Synthesis Controls Blood Pressure by Regulating Signal Transduction and NO via Ceramide","volume":"75","author":"Cantalupo","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib85","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.ATV.0000194074.59584.42","article-title":"Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium","volume":"26","author":"De Palma","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib86","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev-biophys-070317-033309","article-title":"The physical properties of ceramides in membranes","volume":"47","author":"Alonso","year":"2018","journal-title":"Annu Rev Biophys"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib87","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cis.2017.07.014","article-title":"The enzymatic sphingomyelin to ceramide conversion increases the shear membrane viscosity at the air-water interface","volume":"247","author":"Catapano","year":"2017","journal-title":"Adv Colloid Interface Sci"},{"issue":"5867","key":"10.1016\/j.atherosclerosis.2026.120774_bib88","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.1153124","article-title":"Ceramide triggers budding of exosome vesicles into Multivesicular endosomes","volume":"319","author":"Trajkovic","year":"2008","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120774_bib89","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1194\/jlr.M500060-JLR200","article-title":"Ceramide displaces cholesterol from lipid rafts and decreases the association of the cholesterol binding protein caveolin-1","volume":"46","author":"Yu","year":"2005","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib90","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1161\/ATVBAHA.119.312766","article-title":"Ceramide 1-Phosphate protects endothelial colony-forming cells from apoptosis and increases vasculogenesis in vitro and in vivo","volume":"39","author":"Mena","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120774_bib91","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/stem.1291","article-title":"Ceramide-1-phosphate regulates migration of multipotent stromal cells and endothelial progenitor cells--implications for tissue regeneration","volume":"31","author":"Kim","year":"2013","journal-title":"Stem Cell"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120774_bib92","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.3934","article-title":"Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure","volume":"21","author":"Cantalupo","year":"2015","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120774_bib93","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/CIRCRESAHA.123.323826","article-title":"Rewiring endothelial sphingolipid metabolism to favor S1P over ceramide protects from coronary atherosclerosis","volume":"134","author":"Manzo","year":"2024","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib94","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/s41467-025-56869-9","article-title":"Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases","volume":"16","author":"Rubinelli","year":"2025","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib95","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/CIRCRESAHA.115.303881","article-title":"Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation","volume":"115","author":"Freed","year":"2014","journal-title":"Circ Res"},{"issue":"23_suppl_1","key":"10.1016\/j.atherosclerosis.2026.120774_bib96","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120774_bib97","doi-asserted-by":"crossref","first-page":"23792","DOI":"10.3390\/ijms151223792","article-title":"The role of reactive oxygen species in microvascular remodeling","volume":"15","author":"Staiculescu","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib98","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/ATVBAHA.117.309228","article-title":"Reactive oxygen species generation and atherosclerosis","volume":"37","author":"Nowak","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib99","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ Res"},{"issue":"216","key":"10.1016\/j.atherosclerosis.2026.120774_bib100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-3-7091-1511-4_9","article-title":"Cross talk between ceramide and redox signaling: implications for endothelial dysfunction and renal disease","author":"Li","year":"2013","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib101","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000315104","article-title":"Ceramide in redox signaling and cardiovascular diseases","volume":"26","author":"Li","year":"2010","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib102","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/jcp.22611","article-title":"Neutral sphingomyelinase, NADPH oxidase and reactive oxygen species. Role in acute hypoxic pulmonary vasoconstriction","volume":"226","author":"Frazziano","year":"2011","journal-title":"J Cell Physiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib103","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1007\/s12035-018-1286-3","article-title":"The cross-talk between sphingolipids and insulin-like growth factor signaling: significance for aging and neurodegeneration","volume":"56","author":"J\u0119\u015bko","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib104","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3646725","article-title":"Ceramide and Ischemia\/Reperfusion Injury","volume":"2018","author":"He","year":"2018","journal-title":"J Lipids"},{"issue":"43","key":"10.1016\/j.atherosclerosis.2026.120774_bib105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025347118","article-title":"Ceramide accumulation induces mitophagy and impairs \u03b2-oxidation in PINK1 deficiency","volume":"118","author":"Vos","year":"2021","journal-title":"Proc Natl Acad Sci"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2026.120774_bib106","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/01.CIR.0000035650.05921.50","article-title":"Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase","volume":"106","author":"Li","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120774_bib107","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/hh0801.089604","article-title":"Ceramide reduces endothelium-dependent vasodilation by increasing superoxide production in small bovine coronary arteries","volume":"88","author":"Zhang","year":"2001","journal-title":"Circ Res"},{"issue":"45","key":"10.1016\/j.atherosclerosis.2026.120774_bib108","doi-asserted-by":"crossref","first-page":"35617","DOI":"10.1074\/jbc.M007346200","article-title":"Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex","volume":"275","author":"Bourbon","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib109","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0092-8674(00)80183-X","article-title":"Kinase suppressor of Ras is ceramide-activated protein kinase","volume":"89","author":"Zhang","year":"1997","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib110","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1165\/ajrcmb.24.6.4228","article-title":"Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide","volume":"24","author":"Corda","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2026.120774_bib111","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1096\/fj.01-0539com","article-title":"Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis","volume":"15","author":"Birbes","year":"2001","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120774_bib112","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mito.2006.03.002","article-title":"Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations","volume":"6","author":"Siskind","year":"2006","journal-title":"Mitochondrion"},{"issue":"30","key":"10.1016\/j.atherosclerosis.2026.120774_bib113","doi-asserted-by":"crossref","first-page":"26796","DOI":"10.1074\/jbc.M200754200","article-title":"Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins","volume":"277","author":"Siskind","year":"2002","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120774_bib114","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/db11-1399","article-title":"Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120774_bib115","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1124\/mol.63.4.886","article-title":"Activation of endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3' kinase, and Akt","volume":"63","author":"Barsacchi","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib116","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cardiores.2005.06.021","article-title":"Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences","volume":"68","author":"Cai","year":"2005","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib117","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1474-9726.2006.00232.x","article-title":"Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A","volume":"5","author":"Smith","year":"2006","journal-title":"Aging Cell"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120774_bib118","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/ATVBAHA.118.311208","article-title":"nSMase2 (type 2-Neutral sphingomyelinase) deficiency or inhibition by GW4869 reduces inflammation and atherosclerosis in Apoe(-\/-) mice","volume":"38","author":"Lallemand","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8062","key":"10.1016\/j.atherosclerosis.2026.120774_bib119","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41586-025-08792-8","article-title":"Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis","volume":"641","author":"Zhang","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41569-024-01111-0","article-title":"Apolipoprotein B-containing lipoproteins in atherogenesis","volume":"22","author":"Bor\u00e9n","year":"2025","journal-title":"Nat Rev Cardiol"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2026.120774_bib121","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"issue":"27","key":"10.1016\/j.atherosclerosis.2026.120774_bib122","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/eurheartj\/ehy319","article-title":"Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths","volume":"39","author":"Ruuth","year":"2018","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib123","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1172\/JCI118934","article-title":"Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins","volume":"98","author":"Schissel","year":"1996","journal-title":"J Clin Investig"},{"issue":"36","key":"10.1016\/j.atherosclerosis.2026.120774_bib124","doi-asserted-by":"crossref","first-page":"24849","DOI":"10.1016\/S0021-9258(18)54306-4","article-title":"Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages","volume":"266","author":"Xu","year":"1991","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120774_bib125","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1161\/01.ATV.20.12.2607","article-title":"Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation","volume":"20","author":"Marathe","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"44","key":"10.1016\/j.atherosclerosis.2026.120774_bib126","doi-asserted-by":"crossref","first-page":"29127","DOI":"10.1074\/jbc.273.44.29127","article-title":"Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans","volume":"273","author":"O\u00f6rni","year":"1998","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2026.120774_bib127","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1021\/la800714w","article-title":"Effect of sphingomyelinase-mediated generation of ceramide on aggregation of low-density lipoprotein","volume":"24","author":"Walters","year":"2008","journal-title":"Langmuir"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120774_bib128","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1194\/jlr.M023218","article-title":"Conformational changes of apoB-100 in SMase-modified LDL mediate formation of large aggregates at acidic pH","volume":"53","author":"Sneck","year":"2012","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084935","article-title":"Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis","volume":"9","author":"Abbas","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120774_bib130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MOL.0000000000000574","article-title":"Pathways of smooth muscle foam cell formation in atherosclerosis","volume":"30","author":"Pryma","year":"2019","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib131","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1161\/01.ATV.20.6.1572","article-title":"LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells","volume":"20","author":"Llorente-Cort\u00e9s","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2026.120774_bib132","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1161\/01.CIR.0000041434.28573.0B","article-title":"Low-Density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells","volume":"106","author":"Llorente-Cort\u00e9s","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib133","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2015.07.085","article-title":"Circulating soluble low-density lipoprotein receptor-related protein 1 (sLRP1) concentration is associated with hypercholesterolemia: a new potential biomarker for atherosclerosis","volume":"201","author":"de Gonzalo-Calvo","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib134","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2019.06.904","article-title":"Soluble low-density lipoprotein receptor-related protein 1 as a biomarker of coronary risk: predictive capacity and association with clinical events","volume":"287","author":"de Gonzalo-Calvo","year":"2019","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12944-025-02642-2","article-title":"Ceramide signaling in immunity: a molecular perspective","volume":"24","author":"Thakkar","year":"2025","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib136","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41467-024-45582-8","article-title":"Palmitic acid in type 2 diabetes mellitus promotes atherosclerotic plaque vulnerability via macrophage Dll 4 signaling","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib137","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/2193-1801-3-255","article-title":"Inhibition of neutral sphingomyelinases in skeletal muscle attenuates fatty-acid induced defects in metabolism and stress","volume":"3","author":"Verma","year":"2014","journal-title":"SpringerPlus"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib138","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI43378","article-title":"Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice","volume":"121","author":"Holland","year":"2011","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120774_bib139","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1194\/jlr.M063412","article-title":"Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1\u03b1-dependent manner","volume":"57","author":"Kakazu","year":"2016","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cell.2015.05.051","article-title":"A conserved circular network of coregulated lipids modulates innate immune responses","volume":"162","author":"K\u00f6berlin","year":"2015","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib141","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120774_bib142","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med"},{"issue":"8004","key":"10.1016\/j.atherosclerosis.2026.120774_bib143","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41586-024-07098-5","article-title":"IL-10 constrains sphingolipid metabolism to limit inflammation","volume":"627","author":"York","year":"2024","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120774_bib144","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.cell.2011.12.006","article-title":"Metabolic connections during apoptotic cell engulfment","volume":"147","author":"Han","year":"2011","journal-title":"Cell"},{"issue":"51","key":"10.1016\/j.atherosclerosis.2026.120774_bib145","doi-asserted-by":"crossref","first-page":"40322","DOI":"10.1074\/jbc.M110.137604","article-title":"Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages","volume":"285","author":"Petrusca","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib146","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-physiol-031620-093815","article-title":"Ceramides in metabolism: key lipotoxic players","volume":"83","author":"Chaurasia","year":"2021","journal-title":"Annu Rev Physiol"},{"issue":"Suppl","key":"10.1016\/j.atherosclerosis.2026.120774_bib147","doi-asserted-by":"crossref","first-page":"S382","DOI":"10.1194\/jlr.R800032-JLR200","article-title":"Mechanisms and consequences of macrophage apoptosis in atherosclerosis","volume":"50","author":"Seimon","year":"2009","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120774_bib148","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1096\/fj.15.3.807","article-title":"Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis","volume":"15","author":"Deigner","year":"2001","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120774_bib149","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.5551\/jat.32383","article-title":"Acid sphingomyelinase mediates Oxidized-LDL induced apoptosis in macrophage via endoplasmic reticulum stress","volume":"23","author":"Zhao","year":"2016","journal-title":"J Atherosclerosis Thromb"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib150","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1159\/000097815","article-title":"The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability","volume":"26","author":"Clarke","year":"2006","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib151","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.116.305675","article-title":"Sphingolipids contribute to human atherosclerotic plaque inflammation","volume":"36","author":"Edsfeldt","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib152","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2417512122","article-title":"Hypercholesterolemia-induced LXR signaling in smooth muscle cells contributes to vascular lesion remodeling and visceral function","volume":"122","author":"Zhang","year":"2025","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120774_bib153","doi-asserted-by":"crossref","first-page":"E599","DOI":"10.1152\/ajpendo.00439.2004","article-title":"Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle","volume":"288","author":"Dobrzyn","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120774_bib154","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling and membrane homeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120774_bib155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbadis.2004.06.003","article-title":"Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells","volume":"1690","author":"Loidl","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120774_bib156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082379","article-title":"Ceramide mediates Ox-LDL-induced human vascular smooth muscle cell calcification via p38 mitogen-activated protein kinase signaling","volume":"8","author":"Liao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib157","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2016.11.029","article-title":"TLR4\/NF-\u03baB\/Ceramide signaling contributes to Ox-LDL-induced calcification of human vascular smooth muscle cells","volume":"794","author":"Song","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2026.120774_bib158","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120774_bib159","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/er.2007-0025","article-title":"Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism","volume":"29","author":"Holland","year":"2008","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib160","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjp.0703407","article-title":"Apoptosis in the vasculature: mechanisms and functional importance","volume":"130","author":"Mallat","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib161","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/hh1001.090571","article-title":"Current perspective on the role of apoptosis in atherothrombotic disease","volume":"88","author":"Mallat","year":"2001","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120774_bib162","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.atherosclerosis.2011.08.049","article-title":"Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism","volume":"219","author":"Karuna","year":"2011","journal-title":"Atherosclerosis"},{"issue":"1\u20133","key":"10.1016\/j.atherosclerosis.2026.120774_bib163","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1388-1981(02)00147-6","article-title":"Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?","volume":"1582","author":"Okajima","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.120774_bib164","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120774_bib165","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1194\/jlr.M050021","article-title":"Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate","volume":"55","author":"Sutter","year":"2014","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib166","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15043-y","article-title":"Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes","volume":"7","author":"Christensen","year":"2017","journal-title":"Sci Rep"},{"issue":"389","key":"10.1016\/j.atherosclerosis.2026.120774_bib167","doi-asserted-by":"crossref","first-page":"ra79","DOI":"10.1126\/scisignal.aaa2581","article-title":"HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation","volume":"8","author":"Galvani","year":"2015","journal-title":"Sci Signal"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib168","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/ATVBAHA.116.308435","article-title":"High-Density lipoprotein-associated Apolipoprotein M limits endothelial inflammation by delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate receptor 1","volume":"37","author":"Ruiz","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib169","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1096\/fj.201500064","article-title":"Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1","volume":"30","author":"Christensen","year":"2016","journal-title":"FASEB J"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120774_bib170","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1096\/fj.05-3928com","article-title":"Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1\/Rac1, and alpha-actinin","volume":"19","author":"Singleton","year":"2005","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib171","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1074\/jbc.M510434200","article-title":"Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase\/Akt signaling pathways in vascular endothelial cells","volume":"281","author":"Gonzalez","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120774_bib172","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/35060051","article-title":"Activation of Arp2\/3 complex-mediated actin polymerization by cortactin","volume":"3","author":"Uruno","year":"2001","journal-title":"Nat Cell Biol"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.120774_bib173","doi-asserted-by":"crossref","first-page":"24692","DOI":"10.1074\/jbc.M313969200","article-title":"Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase","volume":"279","author":"Dudek","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib174","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yexcr.2004.03.023","article-title":"Interaction of cortactin and Arp2\/3 complex is required for sphingosine-1-phosphate-induced endothelial cell remodeling","volume":"298","author":"Li","year":"2004","journal-title":"Exp Cell Res"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib175","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1083\/jcb.147.5.1009","article-title":"Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior","volume":"147","author":"Sander","year":"1999","journal-title":"J Cell Biol"},{"issue":"6736","key":"10.1016\/j.atherosclerosis.2026.120774_bib176","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/21224","article-title":"Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation","volume":"399","author":"Dimmeler","year":"1999","journal-title":"Nature"},{"issue":"6736","key":"10.1016\/j.atherosclerosis.2026.120774_bib177","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/21218","article-title":"Regulation of endothelium-derived nitric oxide production by the protein kinase Akt","volume":"399","author":"Fulton","year":"1999","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120774_bib178","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0092-8674(00)81661-X","article-title":"Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate","volume":"99","author":"Lee","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib179","doi-asserted-by":"crossref","first-page":"L258","DOI":"10.1152\/ajplung.00311.2002","article-title":"Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products","volume":"285","author":"Schaphorst","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib180","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1172\/JCI12450","article-title":"Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement","volume":"108","author":"Garcia","year":"2001","journal-title":"J Clin Investig"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib181","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/ATVBAHA.121.316725","article-title":"Apolipoprotein M and Sphingosine-1-Phosphate receptor 1 promote the transendothelial transport of high-density lipoprotein","volume":"41","author":"Velagapudi","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120774_bib182","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bbalip.2008.06.008","article-title":"S1P and eNOS regulation","volume":"1781","author":"Igarashi","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib183","doi-asserted-by":"crossref","first-page":"H2045","DOI":"10.1152\/ajpheart.01089.2002","article-title":"Sphingosine 1-phosphate and control of vascular tone","volume":"284","author":"Dantas","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6474","key":"10.1016\/j.atherosclerosis.2026.120774_bib184","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/368850a0","article-title":"Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle","volume":"368","author":"Bolotina","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1189\/jlb.1103567","article-title":"Sphingosine 1-phosphate and its type 1 G protein-coupled receptor: trophic support and functional regulation of T lymphocytes","volume":"76","author":"Goetzl","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib186","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2016.12.009","article-title":"High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression","volume":"257","author":"Feuerborn","year":"2017","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120774_bib187","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1055\/s-0038-1666870","article-title":"Elevating endogenous Sphingosine-1-Phosphate (S1P) levels improves endothelial function and ameliorates atherosclerosis in low density Lipoprotein receptor-deficient (LDL-R-\/-) mice","volume":"118","author":"Feuerborn","year":"2018","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib188","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/ATVBAHA.110.213496","article-title":"Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis","volume":"31","author":"Skoura","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120774_bib189","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120774_bib190","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/hh1801.096338","article-title":"Role of the sphingosine 1-Phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration","volume":"89","author":"Kluk","year":"2001","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib191","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1161\/CIRCRESAHA.107.159228","article-title":"Sphingosine 1-Phosphate receptor 2 negatively regulates neointimal Formation in mouse arteries","volume":"101","author":"Shimizu","year":"2007","journal-title":"Circ Res"},{"issue":"41","key":"10.1016\/j.atherosclerosis.2026.120774_bib192","doi-asserted-by":"crossref","first-page":"42422","DOI":"10.1074\/jbc.M405432200","article-title":"Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors","volume":"279","author":"Lockman","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib193","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1160\/TH07-11-0675","article-title":"Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin","volume":"100","author":"Gonz\u00e1lez-D\u00edez","year":"2008","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120774_bib194","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/ATVBAHA.107.161042","article-title":"HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production","volume":"28","author":"T\u00f6lle","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110419","article-title":"Sphingosine 1-phosphate receptor 2 promotes erythrocyte clearance by vascular smooth muscle cells in intraplaque hemorrhage through MFG-E8 production","volume":"98","author":"Pan","year":"2022","journal-title":"Cell Signal"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib196","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4614-0650-1_2","article-title":"Sphingolipids and cardiovascular diseases: Lipoprotein metabolism, atherosclerosis and cardiomyopathy","volume":"721","author":"Jiang","year":"2011","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120774_bib197","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1161\/01.ATV.20.12.2614","article-title":"Plasma sphingomyelin level as a risk factor for coronary artery disease","volume":"20","author":"Jiang","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib198","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-7075-3-5","article-title":"Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease","volume":"3","author":"Schlitt","year":"2006","journal-title":"Nutr Metab"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib199","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1194\/jlr.D008532","article-title":"Blood sphingolipidomics in healthy humans: impact of sample collection methodology","volume":"51","author":"Hammad","year":"2010","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120774_bib200","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/01.ATV.19.11.2648","article-title":"Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix","volume":"19","author":"Marathe","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2026.120774_bib201","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-3084(99)00080-8","article-title":"Secretory sphingomyelinase","volume":"102","author":"Tabas","year":"1999","journal-title":"Chem Phys Lipids"},{"issue":"48","key":"10.1016\/j.atherosclerosis.2026.120774_bib202","doi-asserted-by":"crossref","first-page":"44976","DOI":"10.1074\/jbc.M106455200","article-title":"Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux","volume":"276","author":"Leventhal","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120774_bib203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCRESAHA.109.194613","article-title":"Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice","volume":"105","author":"Liu","year":"2009","journal-title":"Circ Res"},{"issue":"52","key":"10.1016\/j.atherosclerosis.2026.120774_bib204","doi-asserted-by":"crossref","first-page":"37166","DOI":"10.1074\/jbc.M113.512244","article-title":"Sphingomyelin depletion impairs anionic phospholipid inward translocation and induces cholesterol efflux","volume":"288","author":"Gulshan","year":"2013","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120774_bib205","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/ATVBAHA.108.168682","article-title":"Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation","volume":"28","author":"Hailemariam","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120774_bib206","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF02532490","article-title":"Increase of gangliosides in atherosclerotic human aortas","volume":"10","author":"Breckenridge","year":"1975","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120774_bib207","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-2275(20)36996-0","article-title":"Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias","volume":"17","author":"Dawson","year":"1976","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120774_bib208","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1161\/01.ATV.15.10.1607","article-title":"Glycosphingolipid accumulation in the aortic Wall is another feature of human atherosclerosis","volume":"15","author":"Mukhin","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib209","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/glycob\/7.1.57","article-title":"Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues","volume":"7","author":"Chatterjee","year":"1997","journal-title":"Glycobiology"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120774_bib210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11306-018-1392-2","article-title":"Glycosphingolipids promote pro-atherogenic pathways in the pathogenesis of hyperglycemia-induced accelerated atherosclerosis","volume":"14","author":"Dang","year":"2018","journal-title":"Metabolomics"},{"issue":"6\u20137","key":"10.1016\/j.atherosclerosis.2026.120774_bib211","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1515\/hsz-2014-0283","article-title":"Tackling the biophysical properties of sphingolipids to decipher their biological roles","volume":"396","author":"Carreira","year":"2015","journal-title":"Biol Chem"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120774_bib212","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/CIRCULATIONAHA.118.038571","article-title":"Caveolin-1 regulates atherogenesis by attenuating low-density lipoprotein transcytosis and vascular inflammation independently of endothelial nitric oxide synthase activation","volume":"140","author":"Ram\u00edrez","year":"2019","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120774_bib213","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1091\/mbc.e04-03-0189","article-title":"Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol","volume":"15","author":"Sharma","year":"2004","journal-title":"Mol Biol Cell"},{"issue":"43","key":"10.1016\/j.atherosclerosis.2026.120774_bib214","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1093\/eurheartj\/ehab412","article-title":"Glucosylceramide synthase deficiency in the heart compromises \u03b21-adrenergic receptor trafficking","volume":"42","author":"Andersson","year":"2021","journal-title":"Eur Heart J"},{"issue":"6590","key":"10.1016\/j.atherosclerosis.2026.120774_bib215","doi-asserted-by":"crossref","first-page":"eabh1623","DOI":"10.1126\/science.abh1623","article-title":"Sphingolipids control dermal fibroblast heterogeneity","volume":"376","author":"Capolupo","year":"2022","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib216","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/ATVBAHA.109.201673","article-title":"Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE\u22173 Leiden and low-density lipoprotein receptor-\/- mice","volume":"30","author":"Bietrix","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib217","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/01.RES.82.5.540","article-title":"Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro","volume":"82","author":"Arai","year":"1998","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120774_bib218","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood.V84.7.2068.2068","article-title":"Leukocyte-endothelial adhesion molecules","volume":"84","author":"Carlos","year":"1994","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib219","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.immuni.2020.11.003","article-title":"The SPPL3-Defined glycosphingolipid repertoire orchestrates HLA class I-Mediated immune responses","volume":"54","author":"Jongsma","year":"2021","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120774_bib220","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/glycob\/7.5.703","article-title":"Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells","volume":"7","author":"Chatterjee","year":"1997","journal-title":"Glycobiology"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2026.120774_bib221","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1074\/jbc.271.18.10660","article-title":"Lactosylceramide stimulates Ras-GTP loading, kinases (MEK, Raf), p44 mitogen-activated protein kinase, and c-fos expression in human aortic smooth muscle cells","volume":"271","author":"Bhunia","year":"1996","journal-title":"J Biol Chem"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2026.120774_bib222","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1161\/01.CIR.0000148370.60535.22","article-title":"Inhibition of Sphingomyelin synthesis reduces atherogenesis in apolipoprotein E\u2013Knockout mice","volume":"110","author":"Park","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib223","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2008.06.005","article-title":"Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice","volume":"58","author":"Park","year":"2008","journal-title":"Pharmacol Res"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120774_bib224","doi-asserted-by":"crossref","first-page":"10284","DOI":"10.1074\/jbc.M412348200","article-title":"Effect of Myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice","volume":"280","author":"Hojjati","year":"2005","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120774_bib225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10557-022-07378-0","article-title":"The acid sphingomyelinase inhibitor amitriptyline ameliorates TNF-\u03b1-Induced endothelial dysfunction","volume":"38","author":"Ji","year":"2024","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.atherosclerosis.2026.120774_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105187","article-title":"Development and validation of a plasmalogen score as an independent modifiable marker of metabolic health: population based observational studies and a placebo-controlled cross-over study","volume":"105","author":"Beyene","year":"2024","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120774_bib227","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bbadis.2012.05.008","article-title":"Functions of plasmalogen lipids in health and disease","volume":"1822","author":"Braverman","year":"2012","journal-title":"Biochim Biophys Acta Mol Basis Dis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:09:58Z","timestamp":1783112998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026001401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":227,"alternative-id":["S0021915026001401"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120774","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of ceramides and other sphingolipids in atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120774"}}